RAPID, ROBUST, TARGETED DRUG DISCOVERY, POWERED BY AI
We design and develop innovative therapeutics from pioneering Oxford science, with a unique and powerful combination of expertises that sets us apart.
OUR DISTINCTIVE EXPERTISE
With our dual expertises in the specific field of tRNA synthetase enzyme targeting and in AI/Machine Learning – a unique and distinctive combination – we are able to achieve rapid and effective outcomes in developing novel treatments against cancer and other major diseases.